Bionime Corporation (TPE:4737)

Market Cap	3.63B
Revenue (ttm)	1.91B
Net Income (ttm)	-120.35M
Shares Out	67.29M
EPS (ttm)	-1.80
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	151,696
Average Volume	121,795
Open	53.80
Previous Close	54.00
Day's Range	53.20 - 54.00
52-Week Range	43.14 - 73.90
Beta	0.35
RSI	33.19
Earnings Date	Mar 12, 2026

About Bionime

Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Belarus, Algeria, the United Arab Emirates, Egypt, and internationally. The company manufactures and sells blood glucose meters and test strips to medical equipment companies, pharmacies, and hospitals, as well as offers blood glucose monitoring devices and systems under the RIGHTEST brand; a continuous glucose monitoring system under the iFree CGM brand; and medical blood glucose management systems. It is also involved in the prov...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2003
• Employees: 500
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 4737